BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Igarashi K, Nishizawa H, Saiki Y, Matsumoto M. The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis. J Biol Chem 2021;297:101032. [PMID: 34339740 DOI: 10.1016/j.jbc.2021.101032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee J, Roh JL. Epithelial-Mesenchymal Plasticity: Implications for Ferroptosis Vulnerability and Cancer Therapy. Crit Rev Oncol Hematol 2023;:103964. [PMID: 36931615 DOI: 10.1016/j.critrevonc.2023.103964] [Reference Citation Analysis]
2 Shi ZD, Pang K, Wu ZX, Dong Y, Hao L, Qin JX, Wang W, Chen ZS, Han CH. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal Transduct Target Ther 2023;8:113. [PMID: 36906600 DOI: 10.1038/s41392-023-01383-x] [Reference Citation Analysis]
3 Wang RX, Gu X, Zhang SX, Zhao YJ, Zhang HJ, Li FY. Deletion of BACH1 alleviates ferroptosis and protects against LPS-triggered acute lung injury by activating Nrf2/HO-1 signaling pathway. Biochem Biophys Res Commun 2023;644:8-14. [PMID: 36621150 DOI: 10.1016/j.bbrc.2023.01.002] [Reference Citation Analysis]
4 Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Motahhary M, Saghari S, Sharifi L, Bokaie S, Mirzaei S, Entezari M, Aref AR, Salimimoghadam S, Rashidi M, Taheriazam A, Hushmandi K. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions. Biomed Pharmacother 2023;158:114168. [PMID: 36916439 DOI: 10.1016/j.biopha.2022.114168] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ling H, Xiao H, Luo T, Lin H, Deng J. Role of Ferroptosis in Regulating the Epithelial-Mesenchymal Transition in Pulmonary Fibrosis. Biomedicines 2023;11. [PMID: 36672671 DOI: 10.3390/biomedicines11010163] [Reference Citation Analysis]
6 Takemoto K, Kobatake K, Miura K, Fukushima T, Babasaki T, Miyamoto S, Sekino Y, Kitano H, Goto K, Ikeda K, Hieda K, Hayashi T, Hinata N, Kaminuma O. BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress-related tumorigenicity. Cancer Sci 2023;114:436-48. [PMID: 36178067 DOI: 10.1111/cas.15607] [Reference Citation Analysis]
7 Cong Z, Yuan F, Wang H, Cai X, Zhu J, Tang T, Zhang L, Han Y, Ma C. BTB domain and CNC homolog 1 promotes glioma invasion mainly through regulating extracellular matrix and increases ferroptosis sensitivity. Biochim Biophys Acta Mol Basis Dis 2022;1868:166554. [PMID: 36181980 DOI: 10.1016/j.bbadis.2022.166554] [Reference Citation Analysis]
8 Ahuja M, Kaidery NA, Dutta D, Attucks OC, Kazakov EH, Gazaryan I, Matsumoto M, Igarashi K, Sharma SM, Thomas B. Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease. Antioxidants (Basel) 2022;11:1780. [PMID: 36139853 DOI: 10.3390/antiox11091780] [Reference Citation Analysis]
9 Liu L, Matsumoto M, Matsui-watanabe M, Ochiai K, Callens BKK, Nguyen LC, Kozuki Y, Tanaka M, Nishizawa H, Igarashi K. BACH1 Expression Is Promoted by Tank Binding Kinase 1 (TBK1) in Pancreatic Cancer Cells to Increase Iron and Reduce the Expression of E-Cadherin. Antioxidants 2022;11:1460. [DOI: 10.3390/antiox11081460] [Reference Citation Analysis]
10 Chang LC, Fan CW, Tseng WK, Chen JR, Hua CC. The tumor/normal tissue ratio of Keap1 protein is a predictor for lymphovascular invasion in colorectal cancer: A correlation study between the Nrf2 and KRas pathways. Biomarkers 2022;:1-12. [PMID: 35830714 DOI: 10.1080/1354750X.2022.2102211] [Reference Citation Analysis]
11 Aubin RG, Troisi EC, Montelongo J, Alghalith AN, Nasrallah MP, Santi M, Camara PG. Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma. Nat Commun 2022;13:3936. [PMID: 35803925 DOI: 10.1038/s41467-022-31683-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Liu S, Pi J, Zhang Q. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway. Redox Biol 2022;54:102389. [PMID: 35792437 DOI: 10.1016/j.redox.2022.102389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
13 Bathish B, Robertson H, Dillon JF, Dinkova-Kostova AT, Hayes JD. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2. Free Radic Biol Med 2022;188:221-61. [PMID: 35728768 DOI: 10.1016/j.freeradbiomed.2022.06.226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yang X, Wang Y, Zhao J, Rong H, Chen Y, Xiong M, Ye X, Yu S, Hu H. Coordinated regulation of BACH1 and mitochondrial metabolism through tumor-targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.06.009] [Reference Citation Analysis]
15 Zhao J, Wang Y, Tao L, Chen L. Iron Transporters and Ferroptosis in Malignant Brain Tumors. Front Oncol 2022;12:861834. [DOI: 10.3389/fonc.2022.861834] [Reference Citation Analysis]
16 Ryter SW. Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders. Antioxidants 2022;11:555. [DOI: 10.3390/antiox11030555] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
17 Nishizawa H, Yamanaka M, Igarashi K. Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal. FEBS J 2022. [PMID: 35107212 DOI: 10.1111/febs.16382] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
18 Igarashi K, Nishizawa H, Matsumoto M. Iron in Cancer Progression: Does BACH1 Promote Metastasis by Altering Iron Homeostasis? Subcellular Biochemistry 2022. [DOI: 10.1007/978-3-031-07634-3_2] [Reference Citation Analysis]
19 Ebrahimi N, Adelian S, Shakerian S, Afshinpour M, Chaleshtori SR, Rostami N, Hamblin MR, Aref AR. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: implications for inflammation and cancer therapy. Cytokine & Growth Factor Reviews 2022. [DOI: 10.1016/j.cytogfr.2022.01.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
20 Dietrich C, Hofmann TG. Ferroptosis Meets Cell-Cell Contacts. Cells 2021;10:2462. [PMID: 34572111 DOI: 10.3390/cells10092462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]